No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects*
-
Bone Density / drug effects*
-
Bone Density Conservation Agents / administration & dosage*
-
Breast Neoplasms / drug therapy
-
Chemotherapy, Adjuvant / adverse effects
-
Clinical Trials, Phase III as Topic
-
Diphosphonates / administration & dosage*
-
Female
-
Humans
-
Imidazoles / administration & dosage*
-
Osteoporosis / chemically induced
-
Osteoporosis / prevention & control*
-
Survival Analysis
-
Treatment Outcome
-
Women's Health
-
Zoledronic Acid
Substances
-
Antineoplastic Agents
-
Bone Density Conservation Agents
-
Diphosphonates
-
Imidazoles
-
Zoledronic Acid